Veterinary Medicines

LYSVULPEN, Perorální suspenze

Authorised
  • Rabies virus, strain SAD Bern, Live
Download as PDF

Product identification

Medicine name:
LYSVULPEN, Perorální suspenze
Active substance:
  • Rabies virus, strain SAD Bern, Live
Target species:
  • Fox
  • Raccoon dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Bern, Live
    180000000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Fox
    • Raccoon dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07BD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/078/09-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."